[ad_1]
Global market for malaria vaccines
According to statistics published by the World Health Organization (WHO), nearly half of the world's population is exposed to malaria. This has in turn prompted various health care organizations to become more interested in this critical illness. Global non-profit organizations such as the Melinda Gates Foundation and PATH are working to put in place preventative measures and save lives in many areas affected by malaria. Africa represents the largest number of malaria cases and, therefore, this region is the main target of the launch of the first malaria vaccine developed by GlaxoSmithKline plc. Mosquirix received EU approval in 2015 and is currently the subject of a pilot study in Africa.
Get an example of an exclusive report at: www.coherentmarketinsights.com/insight/request-sample/37
African populations use insecticide-treated mosquito nets and indoor insecticide sprays to prevent malaria vectors. The use of insecticide-treated mosquito nets in Africa increased by 80% between 2010 and 2015 (WHO). In addition, a number of anti-mosquito products (patches, creams, coils, mats, liquids, etc.) are marketed worldwide. In addition, non-profit organizations provide cheap and often free treatment facilities for the malaria-affected population in Africa. In addition, GSK is committed to selling vaccines at a significantly lower cost, relinquishing its huge profit margins to support global programs for malaria eradication. In addition, with more malaria vaccines being researched, the malaria vaccine market is expected to grow significantly in the near future.
The global market for malaria vaccines is expected to be valued at US $ 8.5 million in 2018 and a CAGR of 102.8% over the forecast period (2018-2024).
Key players worldwide:
Among the main companies covered in this study are GlaxoSmithKline plc, Sanaria Inc., Nobelpharma Co., Ltd., Sumaya Biotech and GenVec Inc.
Contents
1. Research objective and hypothesis
◦ Research objectives
◦ Hypotheses
◦ Abbreviations
2. Market view
◦ Description of the report
▪ Definition and scope of the market
◦ Summary
▪ Market extract by type of vaccine
▪ Market extract by agent
▪ Market extract per distribution channel
▪ Market extract by geography
◦ Consistent opportunity map (COM)
Huge potential in the malaria vaccine market
The potential for malaria vaccines is estimated to be enormous, as a large portion of the population, exposed to 90% to 95%, presents a risk of infection in Africa and South-East Asia. The advent of vaccines for the adult population would be a major breakthrough for the malaria vaccine market. Below are some alarming statistics that highlight the need for a malaria vaccine:
• Artemisinin resistance has been detected in five countries: Laos, Cambodia, Myanmar, Vietnam and Thailand.
• Cases of resistance to the parasite P. falciparum against the most available antimalarial drugs are reported
• According to the National Vector-borne Disease Control Program, almost 95% of the Indian population resides in malaria-endemic areas
• An estimated 214 million cases of malaria worldwide in 2015 (WHO)
• Africa is the most affected region with 90% of deaths from malaria in 2015 reported in Africa (WHO)
• Pregnant women, children under 5 and tourists from countries with low malaria incidence rates are identified as the most-at-risk target population for malaria.
The global market for malaria vaccines is expected to grow rapidly with the upcoming launch of the first malaria vaccine.
Request for customization of the research report @ www.coherentmarketinsights.com/insight/request-customizat …
Market Taxonomy
This report segments the global malaria vaccine market by vaccine type, agent, distribution channel and geography. Based on the type of vaccine, the malaria vaccine market is clbadified into the following categories: pre-erythrocyte vaccine, erythrocyte vaccine and multi-antigen vaccine. On the basis of the agent, the market for malaria vaccines is clbadified in Plasmodium Falciparum and Plasmodium Vivax. Based on the distribution channel, the malaria vaccine market is clbadified in hospitals, clinics and community centers. For a full understanding of the market dynamics, the global market for malaria vaccines is badyzed across key geographic regions, namely North America, Europe, Asia-Pacific, Asia and the Pacific. Latin America, Africa and the Middle East. Each of these regions is badyzed on the basis of the results of the markets of the main countries of these regions for a global understanding of the market.
Increase in Accessibility and Government Support to Contribute to the Growth of the Malaria Vaccine Market
WHO has established a Global Technical Strategy for Malaria Control 2016-2030 (GTS) in 2015, with some targets, including one aimed at eliminating malaria in at least 10 countries. Similarly, the Government of India has established Drug Distribution Centers (DDCs) and Fever Treatment Depots in rural areas to facilitate access to antimalarial drugs. Regular monitoring and surveillance of various government programs has reduced the number of malaria cases in India from 2.03 million in 2010 to 1.1 million in 2015. The support provided by these national and global initiatives will stimulate the growth of malaria vaccine market during the forecast period.
Many non-profit organizations and pharmaceutical companies are currently conducting research on malaria vaccines. About 31 trials are underway for the development of a malaria vaccine, including some at the blood stage. The availability of funds and government support programs will encourage the commercialization of the product with positive test results, thus reinforcing the growth trajectory of the malaria vaccine market.
The falciparum vaccine market is expected to drive the growth of key vaccine candidates targeting this parasite. The revenues generated by the community centers should be high because the demand for preventive treatment methods is strong for this segment of end-users.
For more information on this market: www.coherentmarketinsights.com/insight/talk-to-badyst/37
About consistent market badysis
Coherent Market Insights is a leading market research and advisory firm offering ready-made underwriting research reports, customized market research, consulting and competitive badysis through a variety of industry trend recommendations. emerging markets, technologies and opportunities in absolute dollars.
Contact us
Mr. Shah
Coherent market overview
1001 4th Ave, # 3200
Seattle, WA 98154
Tel: + 1-206-701-6702
Email: [email protected]
This press release was published on openPR.
Source link
